Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dolby Laboratories, Inc. M&A Activity 2014

Nov 3, 2014

30828_rns_2014-11-03_88d1b2d1-2f1c-43ac-a3a1-8e0a482e66db.zip

M&A Activity

Open in viewer

Opens in your device viewer

8-K 1 d815220d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

October 31, 2014

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

Delaware 001-32431 90-0199783
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

100 Potrero Avenue

San Francisco, CA 94103-4813

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section 8 – Other Events

Item 8.01 Other Events.

On October 31, 2014, Dolby Laboratories, Inc. completed its acquisition of Doremi Labs. The press release announcing the completion of the transaction is attached as Exhibit 99.1.

Section 9 – Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
99.1 Press Release of Dolby Laboratories, Inc. dated November 3, 2014

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOLBY LABORATORIES, INC.
By: /s/ A NDY S HERMAN
Andy Sherman
Executive Vice President, General Counsel
and Secretary

Date: November 3, 2014

EXHIBIT INDEX

Exhibit No. Description
99.1 Press Release of Dolby Laboratories, Inc. dated November 3, 2014